PUBLISHER: Inkwood Research | PRODUCT CODE: 1408463
PUBLISHER: Inkwood Research | PRODUCT CODE: 1408463
The Japan eyelid surgery blepharoplasty market is anticipated to register a CAGR of 7.51% during the forecasted period. The market growth of the country is supplemented by factors such as growing awareness of cosmetic efficacy and surgical device advancements. The base year considered for the market study is 2023, and the forecast years are from 2024 to 2032.
Blepharoplasty costs in Japan are notably lower compared to equivalent rates in Western countries. The pricing fluctuates widely based on factors such as surgeon reputation and clinic branding. Even in Tokyo, the average charges range from $824 to $1030. It's important to note that Japan's universal public health insurance does not cover cosmetic procedures, necessitating out-of-pocket payments for individuals seeking such treatments.
Moreover, Japan boasts a high-quality medical infrastructure that guarantees certified specialists for interventions such as blepharoplasty. Surgeons undergo a minimum of 8 years of intensive, standardized residency training, specializing in precision techniques tailored to delicate facial alterations. Ongoing advancements in technologies like 3D printing and assisted robotics indicate that Japanese surgeons will continue to maintain global competitiveness, contributing to further domestic growth. Such factors are expected to drive the market growth in Japan during the forecast period.
Some of the eminent companies in the market are: Lumenis Be Ltd, LightScalpel, Ioptima, etc.